Skip to main content
Top
Published in: BMC Public Health 1/2014

Open Access 01-12-2014 | Research article

Tuberculosis case finding and isoniazid preventive therapy among people living with HIV at public health facilities of Addis Ababa, Ethiopia: a cross-sectional facility based study

Authors: Amenu Wesen Denegetu, Bethabile Lovely Dolamo

Published in: BMC Public Health | Issue 1/2014

Login to get access

Abstract

Background

Activities to decrease the burden of tuberculosis (TB) among people living with HIV (PLHIV) include intensified TB case-finding (ICF), Isoniaizid (INH) preventive therapy (IPT) and infection control in health-care and congregate settings (IC). Information about the status of collaborative TB/HIV care services which decreases the burden of TB among PLHIV in Ethiopia is limited. The purpose of the study was to assess TB case finding and provision of IPT among PLHIV in Addis Ababa.

Methods

A cross sectional, facility-based survey was conducted between June 2011 and August 2011. Data was collected by interviewing 849 PLHIV from ten health facilities in Addis Ababa. Both descriptive and inferential statistics were used to analyze findings and the results are described in this report.

Results

The proportion of PLHIV who have been screened for TB during any one of their follow-up cares was 92.8%. Eighty eight (10.4%) of the study participants have been diagnosed for TB during their HIV follow-up cares. PLHIV who had never been diagnosed for TB before they knew their positive HIV status were nearly four times more likely to be diagnosed for TB during follow-up cares than those diagnosed before (AOR [95% CI]: 3.78 [1.69-8.43]). Nearly a third (28.7%) of all interviewed PLHIV self reported that they had been treated with IPT.

Conclusions

It can be concluded that ICF for TB and IPT among PLHIV in Addis Ababa need boosting. Hence, it is recommended to put into practice the national and global guidelines to improve ICF and IPT among PLHIV in the city.
Appendix
Available only for authorised users
Literature
8.
go back to reference Getahun H, Gunneberg C, Granich R, Nunn P: HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010, 50 (Suppl): 3S201-3S207. Getahun H, Gunneberg C, Granich R, Nunn P: HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010, 50 (Suppl): 3S201-3S207.
9.
go back to reference Wesen A, Mitke G: Screening and case detection for tuberculosis among people living with HIV in Addis Ababa, Ethiopia. Ethiop Med J. 2009, 47 (2): 109-115.PubMed Wesen A, Mitke G: Screening and case detection for tuberculosis among people living with HIV in Addis Ababa, Ethiopia. Ethiop Med J. 2009, 47 (2): 109-115.PubMed
10.
go back to reference Andrea AH, Wafaa ME: Integration of tuberculosis and HIV services in Sub-Saharan Africa: lessons learned. Clin Infect Dis. 2010, 50 (Suppl 3): S238-S244. Andrea AH, Wafaa ME: Integration of tuberculosis and HIV services in Sub-Saharan Africa: lessons learned. Clin Infect Dis. 2010, 50 (Suppl 3): S238-S244.
11.
go back to reference Lawn SD, Motasim B, Wood R: Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS. 2005, 19: 2109-2116. 10.1097/01.aids.0000194808.20035.c1.CrossRefPubMed Lawn SD, Motasim B, Wood R: Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS. 2005, 19: 2109-2116. 10.1097/01.aids.0000194808.20035.c1.CrossRefPubMed
12.
go back to reference Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S: How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis. 2005, 191 (2): 150-158. 10.1086/426827.CrossRefPubMed Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S: How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis. 2005, 191 (2): 150-158. 10.1086/426827.CrossRefPubMed
15.
go back to reference Chan CK, Alvarez BF, Wong KH, et al: The epidemiology and clinical manifestations of human immunodeficiency virus-associated tuberculosis in Hong Kong. Hong Kong Med J. 2010, 16 (3): 192-198.PubMed Chan CK, Alvarez BF, Wong KH, et al: The epidemiology and clinical manifestations of human immunodeficiency virus-associated tuberculosis in Hong Kong. Hong Kong Med J. 2010, 16 (3): 192-198.PubMed
16.
go back to reference Memon AR, Memon MA, Altaf A, et al: Frequency of dual tuberculosis/human immunodeficiency virus infection in patients presenting at tertiary care centres at Karachi. J Coll Physicians and Surgeons Pakistan. 2007, 17 (10): 591-593. Memon AR, Memon MA, Altaf A, et al: Frequency of dual tuberculosis/human immunodeficiency virus infection in patients presenting at tertiary care centres at Karachi. J Coll Physicians and Surgeons Pakistan. 2007, 17 (10): 591-593.
17.
go back to reference Gabunia P, Salakaia A, Kiria N, et al: TB/HIV co infection in Georgia. Georgian Med News. 2008, 165: 7-10.PubMed Gabunia P, Salakaia A, Kiria N, et al: TB/HIV co infection in Georgia. Georgian Med News. 2008, 165: 7-10.PubMed
18.
go back to reference Badri M, Wilson D, Wood R: Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet. 2002, 359: 2059-2064. 10.1016/S0140-6736(02)08904-3.CrossRefPubMed Badri M, Wilson D, Wood R: Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet. 2002, 359: 2059-2064. 10.1016/S0140-6736(02)08904-3.CrossRefPubMed
19.
go back to reference Lawn SD, Kranzer K, Wood R: Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med. 2009, 30: 685-699. 10.1016/j.ccm.2009.08.010.CrossRefPubMedPubMedCentral Lawn SD, Kranzer K, Wood R: Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med. 2009, 30: 685-699. 10.1016/j.ccm.2009.08.010.CrossRefPubMedPubMedCentral
20.
go back to reference Brodt HR, Kamps BS, Gute P, et al: Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS. 1997, 11: 1731-1738. 10.1097/00002030-199714000-00010.CrossRefPubMed Brodt HR, Kamps BS, Gute P, et al: Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS. 1997, 11: 1731-1738. 10.1097/00002030-199714000-00010.CrossRefPubMed
21.
go back to reference Woldehanna S, Volmink J: Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2004, 1: CD000171-PubMed Woldehanna S, Volmink J: Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2004, 1: CD000171-PubMed
22.
go back to reference Grant AD, Charalambous S, Fielding KL, et al: Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study. JAMA. 2005, 293 (22): 2719-2725. 10.1001/jama.293.22.2719.CrossRefPubMed Grant AD, Charalambous S, Fielding KL, et al: Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study. JAMA. 2005, 293 (22): 2719-2725. 10.1001/jama.293.22.2719.CrossRefPubMed
23.
go back to reference Golub JE, Pronyk P, Mohapi L, et al: Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS. 2009, 23 (5): 631-636. 10.1097/QAD.0b013e328327964f.CrossRefPubMedPubMedCentral Golub JE, Pronyk P, Mohapi L, et al: Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS. 2009, 23 (5): 631-636. 10.1097/QAD.0b013e328327964f.CrossRefPubMedPubMedCentral
24.
go back to reference Haileyesus G, Reuben G, Delphine S, et al: Implementation of Isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS. 2010, 24 (suppl 5): S57-S65. 10.1097/01.aids.0000391023.03037.1f.CrossRef Haileyesus G, Reuben G, Delphine S, et al: Implementation of Isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS. 2010, 24 (suppl 5): S57-S65. 10.1097/01.aids.0000391023.03037.1f.CrossRef
Metadata
Title
Tuberculosis case finding and isoniazid preventive therapy among people living with HIV at public health facilities of Addis Ababa, Ethiopia: a cross-sectional facility based study
Authors
Amenu Wesen Denegetu
Bethabile Lovely Dolamo
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2014
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-14-52

Other articles of this Issue 1/2014

BMC Public Health 1/2014 Go to the issue